Carrie L. Moland
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: United States Food and Drug Administration (2004–2022); Northrop Grumman (United States) (2003); Procter & Gamble (United States) (2003)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Carrie L. Moland's research focuses on investigating the mechanisms and biomarkers of drug-induced cardiotoxicity, particularly in relation to the chemotherapeutic agent doxorubicin. Her work utilizes animal models, specifically mice and rats, to study gene expression changes and identify potential early indicators of cardiac damage. Recent publications have explored the delayed-onset and chronic effects of doxorubicin on the heart, including subclinical cardiotoxicity in mice.
Further research by Moland has examined sex-related differences in doxorubicin-induced cardiotoxicity, investigating the role of specific molecular pathways such as the apelin-APJ system. Additionally, her studies have identified microRNA-34a-5p as a potential circulating biomarker for early detection of doxorubicin-induced chronic cardiotoxicity. Moland's scholarship includes 47 publications and an h-index of 28, with her work being highly cited. She has collaborated with researchers at the National Center for Toxicological Research on multiple shared publications.
Metrics
- h-index: 28
- Publications: 47
- Citations: 3,396
Selected Publications
-
Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice (2022)
-
MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity (2022)
-
Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice (2021)
-
Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F1 mice (2018)
-
Sex and age differences in the expression of liver microRNAs during the life span of F344 rats (2017)
-
Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F1 mice (2016)
-
Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F<sub>1</sub> mice (2016)
-
Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice (2016)
-
Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats (2015)
-
Age and sex differences in kidney microRNA expression during the life span of F344 rats (2015)
-
Sexual Dimorphism in the Expression of Mitochondria-Related Genes in Rat Heart at Different Ages (2015)
-
Human Sex Hormone-Binding Globulin Binding Affinities of 125 Structurally Diverse Chemicals and Comparison with Their Binding to Androgen Receptor, Estrogen Receptor, and α-Fetoprotein (2014)
-
Early biomarkers of doxorubicin-induced heart injury in a mouse model (2014)
-
A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages (2014)
-
Sex differences in kidney gene expression during the life cycle of F344 rats (2013)
Collaboration Network
Top Collaborators
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
- MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
- Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice
Similar Researchers
Based on overlapping research topics